L582-0251 Screening compound: 1-[3-(3-methoxybenzenesulfonamido)benzoyl]-N-(2-methylpropyl)piperidine-4-carboxamide

L582-0251 Screening compound: 1-[3-(3-methoxybenzenesulfonamido)benzoyl]-N-(2-methylpropyl)piperidine-4-carboxamide
L582-0251 Screening compound: 1-[3-(3-methoxybenzenesulfonamido)benzoyl]-N-(2-methylpropyl)piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L582-0251
1-[3-(3-methoxybenzenesulfonamido)benzoyl]-N-(2-methylpropyl)piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L582-0251

Molecular Formula

C24H31N3O5S (C24 H31 N3 O5 S)

Compound Name

1-[3-(3-methoxybenzenesulfonamido)benzoyl]-N-(2-methylpropyl)piperidine-4-carboxamide

IUPAC name

1-[3-(3-methoxybenzenesulfonamido)benzoyl]-N-(2-methylpropyl)piperidine-4-carboxamide

SMILES

CC(C)CNC(C(CC1)CCN1C(c1cccc(NS(c2cc(OC)ccc2)(=O)=O)c1)=O)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

473.59

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.860

Distribution Coefficient, logD

2.858

Water Solubility, LogSw

-3.54

Polar Surface Area

89.765

Acid Dissociation Constant (pKa)

9.66

Base Dissociation Constant (pKb)

1.07

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

41.70

L582-0251 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Protein-Protein Interaction Library (218420 compounds)

Chemokine Receptor-Targeted Library (18382 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Hemic and lymphatic
  • Cardiovascular
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L582-0251 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L582-0251?
Check Price and Availability of L582-0251, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L582-0251 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L582-0251
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L582-0251
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L582-0251 available by request